 | • レポートコード：QYR2104Z6187 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、5 'ヌクレオチダーゼのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単回投与、併用療法）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・5 'ヌクレオチダーゼの市場動向 ・企業の競争状況、市場シェア ・5 'ヌクレオチダーゼの種類別市場規模（単回投与、併用療法） ・5 'ヌクレオチダーゼの用途別市場規模（病院、外来手術センター、その他） ・5 'ヌクレオチダーゼの北米市場規模2016-2027（アメリカ、カナダ） ・5 'ヌクレオチダーゼのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・5 'ヌクレオチダーゼのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・5 'ヌクレオチダーゼの中南米市場規模2016-2027（メキシコ、ブラジル） ・5 'ヌクレオチダーゼの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Corvus Pharmaceuticals、Innate Pharma、MedImmune、Surface Oncology、Vitae Pharmaceuticals） ・結論 |
5′ Nucleotidase (Ecto 5′ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) – 5′-Nucleotidase (5NT) is an intrinsic membrane glycoprotein that is present as an enzyme in a wide variety of mammalian cells. It catalyzes the phosphorylytic cleavage of 5’nucleotides.
Colorectal Cancer, Fallopian Tube Cancer, Gastric Cancer, Metastatic Colorectal Cancer, Others are dominant players in the global 5 Nucleotidase market.
Market Analysis and Insights: Global 5’Nucleotidase Market
The global 5’Nucleotidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global 5’Nucleotidase market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global 5’Nucleotidase market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global 5’Nucleotidase market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global 5’Nucleotidase market.
Global 5’Nucleotidase Scope and Market Size
5’Nucleotidase market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global 5’Nucleotidase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Single Dose
Combination Therapy
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
Corvus Pharmaceuticals
Innate Pharma
MedImmune
Surface Oncology
Vitae Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 5’Nucleotidase Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Single Dose
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global 5’Nucleotidase Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global 5’Nucleotidase Market Perspective (2016-2027)
2.2 5’Nucleotidase Growth Trends by Regions
2.2.1 5’Nucleotidase Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 5’Nucleotidase Historic Market Share by Regions (2016-2021)
2.2.3 5’Nucleotidase Forecasted Market Size by Regions (2022-2027)
2.3 5’Nucleotidase Industry Dynamic
2.3.1 5’Nucleotidase Market Trends
2.3.2 5’Nucleotidase Market Drivers
2.3.3 5’Nucleotidase Market Challenges
2.3.4 5’Nucleotidase Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 5’Nucleotidase Players by Revenue
3.1.1 Global Top 5’Nucleotidase Players by Revenue (2016-2021)
3.1.2 Global 5’Nucleotidase Revenue Market Share by Players (2016-2021)
3.2 Global 5’Nucleotidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by 5’Nucleotidase Revenue
3.4 Global 5’Nucleotidase Market Concentration Ratio
3.4.1 Global 5’Nucleotidase Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 5’Nucleotidase Revenue in 2020
3.5 5’Nucleotidase Key Players Head office and Area Served
3.6 Key Players 5’Nucleotidase Product Solution and Service
3.7 Date of Enter into 5’Nucleotidase Market
3.8 Mergers & Acquisitions, Expansion Plans
4 5’Nucleotidase Breakdown Data by Type
4.1 Global 5’Nucleotidase Historic Market Size by Type (2016-2021)
4.2 Global 5’Nucleotidase Forecasted Market Size by Type (2022-2027)
5 5’Nucleotidase Breakdown Data by Application
5.1 Global 5’Nucleotidase Historic Market Size by Application (2016-2021)
5.2 Global 5’Nucleotidase Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America 5’Nucleotidase Market Size (2016-2027)
6.2 North America 5’Nucleotidase Market Size by Type
6.2.1 North America 5’Nucleotidase Market Size by Type (2016-2021)
6.2.2 North America 5’Nucleotidase Market Size by Type (2022-2027)
6.2.3 North America 5’Nucleotidase Market Size by Type (2016-2027)
6.3 North America 5’Nucleotidase Market Size by Application
6.3.1 North America 5’Nucleotidase Market Size by Application (2016-2021)
6.3.2 North America 5’Nucleotidase Market Size by Application (2022-2027)
6.3.3 North America 5’Nucleotidase Market Size by Application (2016-2027)
6.4 North America 5’Nucleotidase Market Size by Country
6.4.1 North America 5’Nucleotidase Market Size by Country (2016-2021)
6.4.2 North America 5’Nucleotidase Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe 5’Nucleotidase Market Size (2016-2027)
7.2 Europe 5’Nucleotidase Market Size by Type
7.2.1 Europe 5’Nucleotidase Market Size by Type (2016-2021)
7.2.2 Europe 5’Nucleotidase Market Size by Type (2022-2027)
7.2.3 Europe 5’Nucleotidase Market Size by Type (2016-2027)
7.3 Europe 5’Nucleotidase Market Size by Application
7.3.1 Europe 5’Nucleotidase Market Size by Application (2016-2021)
7.3.2 Europe 5’Nucleotidase Market Size by Application (2022-2027)
7.3.3 Europe 5’Nucleotidase Market Size by Application (2016-2027)
7.4 Europe 5’Nucleotidase Market Size by Country
7.4.1 Europe 5’Nucleotidase Market Size by Country (2016-2021)
7.4.2 Europe 5’Nucleotidase Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific 5’Nucleotidase Market Size (2016-2027)
8.2 Asia-Pacific 5’Nucleotidase Market Size by Type
8.2.1 Asia-Pacific 5’Nucleotidase Market Size by Type (2016-2021)
8.2.2 Asia-Pacific 5’Nucleotidase Market Size by Type (2022-2027)
8.2.3 Asia-Pacific 5’Nucleotidase Market Size by Type (2016-2027)
8.3 Asia-Pacific 5’Nucleotidase Market Size by Application
8.3.1 Asia-Pacific 5’Nucleotidase Market Size by Application (2016-2021)
8.3.2 Asia-Pacific 5’Nucleotidase Market Size by Application (2022-2027)
8.3.3 Asia-Pacific 5’Nucleotidase Market Size by Application (2016-2027)
8.4 Asia-Pacific 5’Nucleotidase Market Size by Region
8.4.1 Asia-Pacific 5’Nucleotidase Market Size by Region (2016-2021)
8.4.2 Asia-Pacific 5’Nucleotidase Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America 5’Nucleotidase Market Size (2016-2027)
9.2 Latin America 5’Nucleotidase Market Size by Type
9.2.1 Latin America 5’Nucleotidase Market Size by Type (2016-2021)
9.2.2 Latin America 5’Nucleotidase Market Size by Type (2022-2027)
9.2.3 Latin America 5’Nucleotidase Market Size by Type (2016-2027)
9.3 Latin America 5’Nucleotidase Market Size by Application
9.3.1 Latin America 5’Nucleotidase Market Size by Application (2016-2021)
9.3.2 Latin America 5’Nucleotidase Market Size by Application (2022-2027)
9.3.3 Latin America 5’Nucleotidase Market Size by Application (2016-2027)
9.4 Latin America 5’Nucleotidase Market Size by Country
9.4.1 Latin America 5’Nucleotidase Market Size by Country (2016-2021)
9.4.2 Latin America 5’Nucleotidase Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 5’Nucleotidase Market Size (2016-2027)
10.2 Middle East & Africa 5’Nucleotidase Market Size by Type
10.2.1 Middle East & Africa 5’Nucleotidase Market Size by Type (2016-2021)
10.2.2 Middle East & Africa 5’Nucleotidase Market Size by Type (2022-2027)
10.2.3 Middle East & Africa 5’Nucleotidase Market Size by Type (2016-2027)
10.3 Middle East & Africa 5’Nucleotidase Market Size by Application
10.3.1 Middle East & Africa 5’Nucleotidase Market Size by Application (2016-2021)
10.3.2 Middle East & Africa 5’Nucleotidase Market Size by Application (2022-2027)
10.3.3 Middle East & Africa 5’Nucleotidase Market Size by Application (2016-2027)
10.4 Middle East & Africa 5’Nucleotidase Market Size by Country
10.4.1 Middle East & Africa 5’Nucleotidase Market Size by Country (2016-2021)
10.4.2 Middle East & Africa 5’Nucleotidase Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb 5’Nucleotidase Introduction
11.1.4 Bristol-Myers Squibb Revenue in 5’Nucleotidase Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Corvus Pharmaceuticals
11.2.1 Corvus Pharmaceuticals Company Details
11.2.2 Corvus Pharmaceuticals Business Overview
11.2.3 Corvus Pharmaceuticals 5’Nucleotidase Introduction
11.2.4 Corvus Pharmaceuticals Revenue in 5’Nucleotidase Business (2016-2021)
11.2.5 Corvus Pharmaceuticals Recent Development
11.3 Innate Pharma
11.3.1 Innate Pharma Company Details
11.3.2 Innate Pharma Business Overview
11.3.3 Innate Pharma 5’Nucleotidase Introduction
11.3.4 Innate Pharma Revenue in 5’Nucleotidase Business (2016-2021)
11.3.5 Innate Pharma Recent Development
11.4 MedImmune
11.4.1 MedImmune Company Details
11.4.2 MedImmune Business Overview
11.4.3 MedImmune 5’Nucleotidase Introduction
11.4.4 MedImmune Revenue in 5’Nucleotidase Business (2016-2021)
11.4.5 MedImmune Recent Development
11.5 Surface Oncology
11.5.1 Surface Oncology Company Details
11.5.2 Surface Oncology Business Overview
11.5.3 Surface Oncology 5’Nucleotidase Introduction
11.5.4 Surface Oncology Revenue in 5’Nucleotidase Business (2016-2021)
11.5.5 Surface Oncology Recent Development
11.6 Vitae Pharmaceuticals
11.6.1 Vitae Pharmaceuticals Company Details
11.6.2 Vitae Pharmaceuticals Business Overview
11.6.3 Vitae Pharmaceuticals 5’Nucleotidase Introduction
11.6.4 Vitae Pharmaceuticals Revenue in 5’Nucleotidase Business (2016-2021)
11.6.5 Vitae Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global 5'Nucleotidase Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Single Dose
Table 3. Key Players of Combination Therapy
Table 4. Global 5'Nucleotidase Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global 5'Nucleotidase Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global 5'Nucleotidase Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global 5'Nucleotidase Market Share by Regions (2016-2021)
Table 8. Global 5'Nucleotidase Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global 5'Nucleotidase Market Share by Regions (2022-2027)
Table 10. 5'Nucleotidase Market Trends
Table 11. 5'Nucleotidase Market Drivers
Table 12. 5'Nucleotidase Market Challenges
Table 13. 5'Nucleotidase Market Restraints
Table 14. Global 5'Nucleotidase Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global 5'Nucleotidase Market Share by Players (2016-2021)
Table 16. Global Top 5'Nucleotidase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5'Nucleotidase as of 2020)
Table 17. Ranking of Global Top 5'Nucleotidase Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by 5'Nucleotidase Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players 5'Nucleotidase Product Solution and Service
Table 21. Date of Enter into 5'Nucleotidase Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million)
Table 24. Global 5'Nucleotidase Revenue Market Share by Type (2016-2021)
Table 25. Global 5'Nucleotidase Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global 5'Nucleotidase Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global 5'Nucleotidase Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global 5'Nucleotidase Revenue Market Share by Application (2016-2021)
Table 29. Global 5'Nucleotidase Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global 5'Nucleotidase Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million)
Table 32. North America 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million)
Table 34. North America 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific 5'Nucleotidase Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific 5'Nucleotidase Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa 5'Nucleotidase Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa 5'Nucleotidase Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa 5'Nucleotidase Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa 5'Nucleotidase Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa 5'Nucleotidase Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa 5'Nucleotidase Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bristol-Myers Squibb Company Details
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb 5'Nucleotidase Product
Table 64. Bristol-Myers Squibb Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. Corvus Pharmaceuticals Company Details
Table 67. Corvus Pharmaceuticals Business Overview
Table 68. Corvus Pharmaceuticals 5'Nucleotidase Product
Table 69. Corvus Pharmaceuticals Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million)
Table 70. Corvus Pharmaceuticals Recent Development
Table 71. Innate Pharma Company Details
Table 72. Innate Pharma Business Overview
Table 73. Innate Pharma 5'Nucleotidase Product
Table 74. Innate Pharma Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million)
Table 75. Innate Pharma Recent Development
Table 76. MedImmune Company Details
Table 77. MedImmune Business Overview
Table 78. MedImmune 5'Nucleotidase Product
Table 79. MedImmune Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million)
Table 80. MedImmune Recent Development
Table 81. Surface Oncology Company Details
Table 82. Surface Oncology Business Overview
Table 83. Surface Oncology 5'Nucleotidase Product
Table 84. Surface Oncology Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million)
Table 85. Surface Oncology Recent Development
Table 86. Vitae Pharmaceuticals Company Details
Table 87. Vitae Pharmaceuticals Business Overview
Table 88. Vitae Pharmaceuticals 5'Nucleotidase Product
Table 89. Vitae Pharmaceuticals Revenue in 5'Nucleotidase Business (2016-2021) & (US$ Million)
Table 90. Vitae Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global 5'Nucleotidase Market Share by Type: 2020 VS 2027
Figure 2. Single Dose Features
Figure 3. Combination Therapy Features
Figure 4. Global 5'Nucleotidase Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. 5'Nucleotidase Report Years Considered
Figure 9. Global 5'Nucleotidase Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global 5'Nucleotidase Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global 5'Nucleotidase Market Share by Regions: 2020 VS 2027
Figure 12. Global 5'Nucleotidase Market Share by Regions (2022-2027)
Figure 13. Global 5'Nucleotidase Market Share by Players in 2020
Figure 14. Global Top 5'Nucleotidase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5'Nucleotidase as of 2020
Figure 15. The Top 10 and 5 Players Market Share by 5'Nucleotidase Revenue in 2020
Figure 16. Global 5'Nucleotidase Revenue Market Share by Type (2016-2021)
Figure 17. Global 5'Nucleotidase Revenue Market Share by Type (2022-2027)
Figure 18. North America 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America 5'Nucleotidase Market Share by Type (2016-2027)
Figure 20. North America 5'Nucleotidase Market Share by Application (2016-2027)
Figure 21. North America 5'Nucleotidase Market Share by Country (2016-2027)
Figure 22. United States 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe 5'Nucleotidase Market Share by Type (2016-2027)
Figure 26. Europe 5'Nucleotidase Market Share by Application (2016-2027)
Figure 27. Europe 5'Nucleotidase Market Share by Country (2016-2027)
Figure 28. Germany 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific 5'Nucleotidase Market Share by Type (2016-2027)
Figure 36. Asia-Pacific 5'Nucleotidase Market Share by Application (2016-2027)
Figure 37. Asia-Pacific 5'Nucleotidase Market Share by Region (2016-2027)
Figure 38. China 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America 5'Nucleotidase Market Share by Type (2016-2027)
Figure 46. Latin America 5'Nucleotidase Market Share by Application (2016-2027)
Figure 47. Latin America 5'Nucleotidase Market Share by Country (2016-2027)
Figure 48. Mexico 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa 5'Nucleotidase Market Share by Type (2016-2027)
Figure 52. Middle East & Africa 5'Nucleotidase Market Share by Application (2016-2027)
Figure 53. Middle East & Africa 5'Nucleotidase Market Share by Country (2016-2027)
Figure 54. Turkey 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE 5'Nucleotidase Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in 5'Nucleotidase Business (2016-2021)
Figure 58. Corvus Pharmaceuticals Revenue Growth Rate in 5'Nucleotidase Business (2016-2021)
Figure 59. Innate Pharma Revenue Growth Rate in 5'Nucleotidase Business (2016-2021)
Figure 60. MedImmune Revenue Growth Rate in 5'Nucleotidase Business (2016-2021)
Figure 61. Surface Oncology Revenue Growth Rate in 5'Nucleotidase Business (2016-2021)
Figure 62. Vitae Pharmaceuticals Revenue Growth Rate in 5'Nucleotidase Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の併用抗体療法市場規模・現状・予測（2021年-2027年） Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination ant…- 世界のエステティック併用療法市場規模・現状・予測（2021年-2027年） Combination treatment in aesthetic market consists of various treatment approaches such as neuromodulators, derma fillers, topical therapies, intense pulsed light photo rejuvenation, laser therapies, radiofrequency-based therapies and ultra-radiofrequency-based therapies. The market is expected to w…
- 世界のエステティック併用療法市場規模・現状・予測（2021年-2027年） Combination treatment in aesthetic market consists of various treatment approaches such as neuromodulators, derma fillers, topical therapies, intense pulsed light photo rejuvenation, laser therapies, radiofrequency-based therapies and ultra-radiofrequency-based therapies. The market is expected to w…
- 世界の外来手術センター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の外来用点滴療法サービス市場規模・現状・予測（2021年-2027年） Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications. Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health ca…